Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:00am, Thursday, 19'th Mar 2026
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
JNJ Stock's Re-Rating: When The Market Finally Sees A Different Company
09:35am, Thursday, 19'th Mar 2026
Question: What caused JNJ stock to rise 70% since early 2025?
CIBC Bancorp USA Inc. Buys Shares of 642,781 Johnson & Johnson $JNJ
05:50am, Thursday, 19'th Mar 2026
CIBC Bancorp USA Inc. bought a new stake in shares of Johnson and Johnson (NYSE: JNJ) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC
2,559 Shares in Johnson & Johnson $JNJ Acquired by Caerus Investment Advisors LLC
04:38am, Thursday, 19'th Mar 2026
Caerus Investment Advisors LLC bought a new stake in Johnson and Johnson (NYSE: JNJ) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange C
4,385 Shares in Johnson & Johnson $JNJ Purchased by ARQ Wealth Advisors LLC
03:58am, Thursday, 19'th Mar 2026
ARQ Wealth Advisors LLC purchased a new stake in shares of Johnson and Johnson (NYSE: JNJ) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 4,385 sha
Asset Dedication LLC Has $3.23 Million Stake in Johnson & Johnson $JNJ
03:58am, Thursday, 19'th Mar 2026
Asset Dedication LLC grew its holdings in Johnson and Johnson (NYSE: JNJ) by 24.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow
01:45am, Thursday, 19'th Mar 2026
J&J has gone through several shifts in recent years -- and demonstrated its strength. The company has many products and platforms that deliver billion-dollar revenue.
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
01:17pm, Wednesday, 18'th Mar 2026
Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi.
J&J or Merck? Key Factors Investors Must Weigh Right Now
11:10am, Wednesday, 18'th Mar 2026
Johnson & Johnson JNJ and Merck MRK are among the top U.S. healthcare giants, making them ideal candidates for a direct comparison.
US FDA approves J&J's oral psoriasis pill
08:31am, Wednesday, 18'th Mar 2026
The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for psoriasis, the company said on Wednesday, paving the way for a more convenient treatment option for patients
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
07:49am, Wednesday, 18'th Mar 2026
Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE offers an innovative new op
Coldstream Capital Management Inc. Raises Stock Holdings in Johnson & Johnson $JNJ
06:44am, Wednesday, 18'th Mar 2026
Coldstream Capital Management Inc. boosted its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 9.8% in the third quarter, according to the company in its most recent 13F filing with the Secur
Cim Investment Management Inc. Has $1.28 Million Stake in Johnson & Johnson $JNJ
04:44am, Wednesday, 18'th Mar 2026
Cim Investment Management Inc. reduced its stake in shares of Johnson and Johnson (NYSE: JNJ) by 50.6% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owne
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
06:45pm, Tuesday, 17'th Mar 2026
Johnson & Johnson (JNJ) reached $238.11 at the closing of the latest trading day, reflecting a -2.09% change compared to its last close.
